Lee Ainslie Verona Pharma PLC Call Options Transaction History
Maverick Capital LTD
- $5.07 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VRNA
# of Institutions
148Shares Held
66.9MCall Options Held
495KPut Options Held
486K-
Ra Capital Management, L.P. Boston, MA7.63MShares$291 Million1.66% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$213 Million7.62% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$153 Million1.9% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$135 Million7.58% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.31MShares$126 Million2.82% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.33B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...